Main Index Search Register Login Who's Online FAQ Links | ||||
2 Online, 0 Active | You are not logged in |
|
General Discourse | |||
All 4 posts | Subject: Pharmacokinetics of hydrocodone... | Please login to post | Down | |||||
BlaseDeviant (Hive Bee) 09-27-04 22:39 No 533458 |
Pharmacokinetics of hydrocodone... | |||||||
Hydrocodone metabolizes by CYP2D6-P450 to hydromorphone, correct? Are there any other active metabolites? Any that account for its effect more than hydrocodone itself does? Hydrocodone itself IS active before being metabolized, but is it also the main drug acting here? Also, is the rate at which it metabolizes to hydromorphone significant enough for the hydromorphone to have an effect... or not? How is hydromorphone metabolized? Is there any way to inhibit hydromorphone's metabolization (I doubt it, but I can hold a glimmer of hope) then? I read on pubmed that when enzyme deficient folks, and folks who had taken quinine (I think it was?) to inhibit metabolization to hydromorphone, it was still abusable, so obviously I guess hydrocodone is active, or else it has another major metabolite(s). But my main concern is stopping/slowing the hydromorphone metabolization, which I'm feeling is probably a pipe dream? Also, do benzos enhance or weaken it? I heard on another forum that gaba modulates dopamine-induced neuron firing, and that one of the proposed theories of opiate euphoria was that opiate receptors when activated, had an (one of many) effect of increasing dopamine, which accounts for PART of the effects. But everyone who's done it says it's good, and I must say that .5 g Halcion + hydrocodone seemed stronger than the same amount the next day, sans Halcion, unless tolerance formed from one day of recent usage (highly unlikely, right?)? However, some say that it just increases sedation, which some people mistake for a better time. I dunno. So differently divine... |
||||||||
jsorex (Hive Addict) 09-28-04 00:05 No 533478 |
British Journal of Clinical Pharmacology ... | |||||||
This artcle here lists the metabolites and the mechanisms. British Journal of Clinical Pharmacology Volume 57 Issue 3 Page 287 - March 2004 DOI:10.1046/j.1365-2125.2003.02002.x CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes This one talks about the inhibition and quinine Effect of Cytochrome P450 2D1 Inhibition on Hydrocodone Metabolism and its Behavioral Consequences in Rats D. M. TOMKINS, S. V. OTTON, N. JOHARCHI, N-Y. LI, R. F. BALSTER, R. F. TYNDALE and E. M. SELLERS DOI:0022-3565/97/2803-1374$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 280, No. 3 Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. JPET 280:1374–1382, 1997 |
||||||||
BlaseDeviant (Hive Bee) 09-29-04 23:49 No 533805 |
Thanks. An interesting note, if I'm reading... | |||||||
Thanks. An interesting note, if I'm reading that correctly, is that only 4.6% of any hydrocodone dose is actually converted into hydromorphone. So differently divine... |
||||||||
BlaseDeviant (Hive Bee) 10-02-04 22:45 No 534212 |
Speaking of pharmacokinetics, does anyone know | |||||||
Speaking of pharmacokinetics, does anyone know WHY SSRIS blunt the effects of opiates? Similar to the DXM + morphine/opiates effect (and it's still argued whether it potentiates analegesia but attenuates euphoria, or potentiates both), it's documented, but unexplained, as far as I know. So differently divine... |
||||||||